title: Renal outcomes in the ONTARGET study.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Nonoguchi
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Nanami
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Hasuike
authors.forename: Takahiro
authors.initials: T
authors.lastname: Kuragano
authors.forename: Takeshi
authors.initials: T
authors.lastname: Nakanishi
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D018579:Patient Selection; D011507:Proteinuria / Q000139:chemically induced*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors